REFERENCES
- Naffakh N, Bohl D, Salvetti A, Moullier P, Danos 0, Heard JM. Gene therapy for lysosomal disorders. Nouv Rev Fr Hematol 1994; 36 Suppl 1: 11–6.
- Chang AG, Wu GY. Gene Therapy: applications to the treatment of gastrointestinal and liver dis-eases. Gastroenterology 1994; 106: 1076–84.
- Schachtner SK, Rome JJ, Hoyt RF, Newman KD, Virmani R, Dichek DA. In vivo adenovirus-mediated gene transfer via the pulmonary artery of rats. Circ Res 1995; 76: 701–9.
- Schmid RM, Weidenbach H, Yamagushi H, Luhrs H, Liptay S, Adler G. Direct gene transfer into the rat pancreas using DNA-liposomes. Eur J Clin Invest 1998; 28: 220–6.
- Thierry AR, Lunardi-Iskandar Y, Bryant JL, Rabinovich P, Gallo RC, Mahan LC. Systemic gene therapy: biodistribution and long-term expression of a transgene in mice. Proc Nati Acad Sci USA 1995; 92: 9742–6.
- Feigner PL, Gadek TR, Holm M, Roman R, Chan HW, Wenz M, Northrop JP, Ringold GM, Danielsen M. Lipofection: a highly efficient, lipid mediated DNA-transfection procedure. Proc Nati Acad Sci USA 1987; 84: 7413–7.
- Miller AD. Human gene therapy comes of age. Nature 1992; 357: 455–60.
- Lyerly HK, DiMaio JM. Gene delivery systems in surgery. Arch Surg 1993; 128: 1197–205.
- Heikkila P, Parpala T, Lukkarinen 0, Weber M, Tryggvason K. Adenovirus-mediated gene transfer into kidney glomeruli using an ex vivo and in vivo kidney perfusion system—first steps towards gene therapy of Alport syndrome. Gene Ther 1996; 3: 21–7.
- Ross MH, Reith EJ, Romrell U. Spleen. In: Ross MH, Reith EJ, Romrell LJ, editors. Histology: a text and atlas. 2nd ed. Baltimore USA: Williams & Wilkins, 1989: 324–8,340-3.
- Trapnell BC, Gorziglia M. Gene therapy using adenoviral vectors. Curr Opin Biotechnol 1994; 5: 617–25.
- Zsengeller ZK, Wert SE, Hull WM, Hu X, Yei S, Trapnell BC, Whitsett JA. Persistence of replication-deficient adenovirus-mediated gene transfer in lungs of immune-deficient [nu/nu] mice. Hum Gene Ther 1995; 6: 457–467.
- Eto Y, Ida H. Molecular studies of Gaucher dis-ease. Jpn J Clin Pathol 1996; 44: 327–34.
- Coppola G, Yan Y, Hantzopoulos P, Segura E, Stroh JG, Calhoun DH. Characterization of glyco-sylated and catalytically active recombinant human alpha-galactosidase A using a baculovirus vector. Gene 1994; 144: 197–203.
- Medin JA, Tudor M, Simovitch R, Quirk JM, Jacobson S, Murray GT, Brady RO. Correction in trans for Fabry disease: expression, secretion and uptake of alpha-galactosidase A in patient-derived cells driven by a high-titer recombinant retroviral vector. Proc Nati Acad Sci USA 1996; 93: 7917–22.
- Baru M, Axelrod JH, Nur I. Lip osome-encapsulated DNA-mediated gene transfer and synthesis of human factor IX in mice. Gene 1995; 161: 143–50.
- Descamps V, Blumenfeld N, Villeval JL, Vainchenker W, Perricaudet M, Beuzard Y. Erythropoietin gene transfer and expression in adult normal mice: use of an adenovirus vector. Hum Gene Ther 1994; 5: 979–85.
- Buben'ik J, S'imov'a J, Buben'ikov'a D, Zeuthen J, Indrov'a M. Interleukin-2 gene therapy of residual EL-4 leukaemia potentiates the effect of cyclophosphamide pretreatment. J Cancer Res Clin Oncol 1995; 121: 39–43.
- Ferkol T, Perales JC, Mularo F, Hanson RW. Receptor-mediated gene transfer into macro-phages. Proc Nati Acad Sci USA 1996; 93: 101–5.